SCHEMBL4010201

SCHEMBL4010201

Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1cn(C)c(=O)c(Nc2ccc(-c3ccc[nH]c3=O)cc2)n1

nearest known ligand 0.69

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
BTK Q06187 20/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1068825 0.89 BTK (0.69) BTK
SCHEMBL13330128 0.89 BTK (0.77) BTK
SCHEMBL1069098 0.88 BTK (0.72) BTK
SCHEMBL1066339 0.88 BTK (0.76) BTK
SCHEMBL1070603 0.88 BTK (0.76) BTK
SCHEMBL1068822 0.88 BTK (0.76) BTK
SCHEMBL1068492 0.88 BTK (0.76) BTK
SCHEMBL1883374 0.87 BTK (0.73) BTK
SCHEMBL1069061 0.87 BTK (0.75) BTK
SCHEMBL1067971 0.87 BTK (0.75) BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2068849-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI Pharmaceuticals, Inc. (US) 2009-06-17 EP disclosed
WO-2008033858-A2 KINASE INHIBITORS, AND METHODS OF USING AND IDENTIFYING KINASE INHIBITORS CGI PHARMACEUTICALS, INC. (US) 2008-03-20 WO disclosed